Ayman Hamed, MD
Physical Medicine & Rehabilitation · Baton Rouge, LANPI 1235162165
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,392 of the $7,369 with a category attached, or 73.2%. 24 manufacturers reported payments, led by Saluda Medical Americas, Inc. at 46.4% of the total. 2025 is the largest year on record at $4,423, more than ten times the $184 reported in 2019. Among physical medicine & rehabilitation clinicians in LA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 155 payments — averaging $47.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Saluda Medical Americas, Inc.$3K
- Si-bone, Inc.$724
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$458
- Nevro Corp.$445
- Medtronic$369
- Spinal Simplicity, LLC$331
- plus $2K from 18 others
What the payments were for
- Travel & lodging$1,92926%
- Food & beverage$5,39273%
- Education$481%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Saluda Medical Americas, Inc. | 33 | $3,423 |
| Si-bone, Inc. | 4 | $724 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 42 | $458 |
| Nevro Corp. | 7 | $445 |
| Medtronic(2 entities) | 6 | $369 |
| Spinal Simplicity, LLC | 3 | $331 |
| Biotronik NRO, Inc. | 4 | $289 |
| IBSA Pharma Inc. | 11 | $205 |
| Biodelivery Sciences International, Inc. | 9 | $199 |
| Abbott | 4 | $139 |
| Collegium Pharmaceutical, Inc. | 6 | $116 |
| Forte Bio-pharma LLC | 5 | $109 |
| Virtus Pharmaceuticals LLC | 4 | $98 |
| Curonix LLC | 1 | $91 |
| Tonix Medicines, Inc. | 1 | $77 |
| Stimwave Technologies Incorporated | 2 | $66 |
| Pfizer | 2 | $53 |
| Valinor Pharma, LLC | 3 | $51 |
| Lundbeck LLC | 2 | $40 |
| Boston Scientific | 2 | $27 |
| Redhill Biopharma Inc. | 1 | $18 |
| Azurity Pharmaceuticals, Inc. | 1 | $16 |
| Daiichi Sankyo Inc. | 1 | $14 |
| Arbor Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Evoke$2,716
- IFUSE IMPLANT SYSTEM$641
- HA MINUTEMAN G3-R$307
- Prospera$201
- Senza$183
- SYNCHROMEDII$171
- Omnia$113
- RESTORE$110
- BELBUCA$105
How this compares
$7,369 in reported general payments places this provider in the 90th percentile of 117 physical medicine & rehabilitation providers in Louisiana.
See all physical medicine & rehabilitation providers in Louisiana →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RelistorMethylnaltrexone Bromide | 59 | $143,407 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 2,749 | $66,866 |
| BelbucaBuprenorphine Hcl | 102 | $60,285 |
| Buprenorphine | 184 | $42,069 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 1,235 | $36,765 |
| Oxycodone Hcl | 279 | $4,620 |
| Tramadol Hcl ErTramadol Hcl | 60 | $3,856 |
| Gabapentin | 309 | $3,530 |
| Morphine Sulfate ErMorphine Sulfate | 136 | $3,478 |
| Butalbital-Acetaminophen-CaffeButalb/Acetaminophen/Caffeine | 34 | $2,437 |
| OxycontinOxycodone Hcl | 12 | $2,310 |
| Pregabalin | 183 | $2,200 |
| Tizanidine Hcl | 201 | $1,748 |
| Methocarbamol | 126 | $1,652 |
| Lidocaine | 19 | $1,594 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $458 | $143,40759 claims |
| Collegium Pharmaceutical, Inc.Belbuca | $116 | $60,285102 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 117 physical medicine & rehabilitation providers in Louisiana.
Other physical medicine & rehabilitation in Baton Rouge
- John E NyboerBaton Rouge$7K
- Scott NyboerBaton Rouge$7K
- Matthew CutrerBaton Rouge$6K
- Christopher BelleauBaton Rouge$3K
- Gray BarrowBaton Rouge$1K
- Mary AndersonBaton Rouge$917
- Jeremy ComeauxBaton Rouge$581
- Kevin HaynesBaton Rouge$449
- Zachary DawesBaton Rouge$212
- William RogenmoserAlexandria$350K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.